Seattle Genetics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

26.07.16	EARNINGS SUMMARY: Details of Seattle Genetics Inc. Q2 Earnings Report (RTTNews)
07.07.16	Nanobiotix Takes A Big Step, VRTX Broadens Pipeline, PFE Aims High With Javelin (RTTNews)
26.05.16	No Pain, Only Gain For INNL, FDA Panel Backs SNY, Wait Continues For SRPT (RTTNews)
18.05.16	Bristol Myers' Opdivo - A Pipeline In Itself... (RTTNews)
28.04.16	EARNINGS SUMMARY: Details of Seattle Genetics Inc. Q1 Earnings Report (RTTNews)
23.02.16	RSMD Branches Out, HOPE For CAPR, Aeolus' Clinical Hold Lifted, SGEN On Track (RTTNews)
09.02.16	Seattle Genetics Issues 2016 Outlook - Quick Facts (RTTNews)
09.02.16	EARNINGS SUMMARY: Details of Seattle Genetics Inc. Q4 Earnings Report (RTTNews)
23.12.15	Seattle Genetics, Bristol-Myers Initiate Phase 1/2 Trial Of ADCETRIS (RTTNews)
06.12.15	Seattle Genetics Highlights Data From SGN-CD19A Antibody-Drug Conjugate Program (RTTNews)
29.10.15	EARNINGS SUMMARY: Details of Seattle Genetics Inc. Q3 Earnings Report (RTTNews)
27.10.15	Seattle Genetics, Takeda Achieve Target Enrollment In Phase 3 ECHELON-1 Trial (RTTNews)
19.10.15	Seattle Genetics Initiates Phase 2 Clinical Trial Of ADCETRIS - Quick Facts (RTTNews)
11.09.15	SGEN Prices Offering At $41/Share (RTTNews)
18.08.15	ESPR On Track, INSY Gets FDA Date, It's A Thumbs Up For SGEN, RPTP (RTTNews)
30.07.15	EARNINGS SUMMARY: Details of Seattle Genetics Inc. Q2 Earnings Report (RTTNews)
21.04.15	AMPE Severely Hurt, INGN Put On Notice, NYMX On The Rise, SGEN Gets FDA Date (RTTNews)
20.04.15	Seattle Genetics Says FDA Accepts SBLA, Grants Priority Review For ADCETRIS (RTTNews)
19.02.15	CBLI Back On Track, HTBX Joins Hands With OncoSec, PRAH In Good Health (RTTNews)
18.02.15	Seattle Genetics Submits Supplemental BLA For Phase 3 AETHERA Trial Of ADCETRIS (RTTNews)
17.02.15	Seattle Genetics Begins Phase1 Trial For Multiple Types Of Advanced Solid Tumors (RTTNews)
10.02.15	Seattle Genetics Loss Narrower Than Estimates (RTTNews)
12.01.15	Seattle Genetics, Bristol-Myers Report Clinical Trial Collaboration (RTTNews)
07.12.14	Seattle Genetics Announces Four-Year Survival Data From ADCETRIS Trial In ALCL (RTTNews)
06.12.14	Seattle Genetics, Takeda Report Phase3 AETHERA Clinical Trial Data From ADCETRIS (RTTNews)
30.10.14	Seattle Genetics Q3 Loss Narrows - Quick Facts (RTTNews)
29.09.14	Seattle Genetics, Takeda Report Positive Data From Phase 3 Trial Of ADCETRIS (RTTNews)
10.09.14	Seattle Genetics, Genmab In New Antibody-Drug Conjugate Collaboration (RTTNews)
12.08.14	Seattle Genetics Begins Phase 1 Trial Of SGN-CD70A For NHL And RCC - Quick Facts (RTTNews)
01.08.14	ALXA Working Its Way, CERS Awaits FDA Decision, XNCR, SGEN Look Ahead To Results (RTTNews)
31.07.14	Seattle Genetics Q2 Loss Widens (RTTNews)
31.05.14	Seattle Genetics Reports Data From Collaborator ADC Programs - Quick Facts (RTTNews)
01.05.14	Seattle Genetics Posts Loss (RTTNews)
09.04.14	ALKS, SGEN To Watch Out, Capstone Dons New Hat, PRTA Pockets $15 Mln (RTTNews)
11.02.14	Seattle Genetics Q4 Loss Widens - Quick Facts (RTTNews)
17.01.14	Seattle Genetics: Takeda Gets Approval For Adcetris In Japan (RTTNews)
07.12.13	Seattle Genetics Presents Interim Phase1 Clinical Data From SGN-CD19A (RTTNews)
06.11.13	MYGN, SGEN Boost Outlook, AMRI On A High, ENDP Opens Wallet, IMGN Slammed (RTTNews)
05.11.13	Seattle Genetics Q3 Loss Widens - Quick Facts (RTTNews)
22.10.13	Oxygen Bio Breathes Anew, KERX Gets FDA Date, Rockwell Continues To Rock (RTTNews)
21.10.13	Seattle Genetics Begins Phase 1 Trial Of ADC Candidate SGN-LIV1A (RTTNews)
21.10.13	Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros (PR Newswire)
15.10.13	Under AAAResearchReports.com Microscope: Amarin Corp. PLC, Elan Corp. PLC, Seattle Genetics Inc., and Cubist Pharma Inc. (PR Newswire)
11.10.13	Seattle Genetics Reports ADCETRIS Data In Frontline Setting On Hodgkin Lymphoma (RTTNews)
07.10.13	Partnerships, Product Recall, New Contracts, Promotions, and Stock Movement - Research Report on Valeant, CareFusion, Envision Healthcare, Seattle Genetics, and Osiris (PR Newswire)
03.10.13	Critical Alerts For Exxon Mobil, Citigroup, Dollar Tree, Oracle, and Seattle Genetics Released By InvestorsObserver (PR Newswire)
16.09.13	Pre-Market Analysis: Amarin Corp. PLC, Elan Corp. PLC, Cubist Pharmaceuticals Inc., and Seattle Genetics Inc. (PR Newswire)
05.09.13	Critical Alerts For Coca Cola, Royal Gold, Rackspace Hosting, Herbalife, and Seattle Genetics Released By InvestorsObserver (PR Newswire)
29.08.13	Clinical Trials, Pipeline Developments, Financial Results, and New Appointments - Research Report on Amarin, Immunomedics, Seattle Genetics, Repros Therapeutics, and LifePoint (PR Newswire)
15.08.13	Seattle Genetics Initiates Phase 2 Trial Of Adcetris In Combination With RCHOP (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	82.24	2.93 %	K V
Part Grp Hldg	1’404.00	1.67 %	K V
CieFinRichemont	170.10	1.10 %	K V
Kuehne+Nagel Int	206.60	0.98 %	K V
Holcim	89.82	0.92 %	K V
ABB	53.58	0.04 %	K V
Givaudan	3’941.00	-0.10 %	K V
Geberit	498.50	-0.46 %	K V
Alcon	80.46	-0.54 %	K V
Sonova Hldg	314.80	-1.16 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Seattle Genetics Inc.

Aktien Top/Flop

Meistgelesene Nachrichten